title: An opportunity to determine optimal treatment of pT3 prostate cancer: the window may be closing.
authors.affiliation: Urology Service, Brooke Army Medical Center, San Antonio, Texas.
authors.forename: I M
authors.initials: IM
authors.lastname: Thompson
authors.forename: J C
authors.initials: JC
authors.lastname: Paradelo
authors.forename: E D
authors.initials: ED
authors.lastname: Crawford
authors.forename: C A
authors.initials: CA
authors.lastname: Coltman
authors.forename: B
authors.initials: B
authors.lastname: Blumenstein
mesh_terms: D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D015996:Survival Rate